Carlson Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Carlson Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-110,000	Closed	-$10.2M	–	194
2021 Q4	$10.2M	Buy	+110,000	New	+$7.25M	0.59%	39
2019 Q1	–	Sell	-45,783	Closed	-$1.78M	–	323
2018 Q4	$1.78M	Buy	+45,783	New	+$1.8M	0.03%	246

Carlson Capital's ARNA Position: Q1 2022 in Review

Carlson Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 110,000 shares — an estimated $10.2M sold.

Carlson Capital first reported a position in ARNA in Q4 2018 and held it in 2 quarters. The position peaked at $10.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Carlson Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Carlson Capital sold 110,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $10.2M.
Carlson Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 2 quarters.
Carlson Capital's Arena Pharmaceuticals Inc position peaked at $10.2M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Carlson Capital's 13F filing for Q1 2022, filed 13 May 2022.